EDWARD GERALD KAY ESTATE enters INTEGRATED BIOPHARMA INC with 3.29M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 11/16/2023ACC: 0001345281-23-000005
10% Owner
Since Mar 2023
3.29M
Baseline shares
100% direct
3.29M
Direct ownership
1 position
238.33K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned3.29M
Total
3.29M direct3.29M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.29M | Direct |
| Total | 3.29M | 3.29M direct |
Derivative Holdings3
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
150K
Shares owned
N/A
Exercise price
0.23
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
21.67K
Shares owned
N/A
Exercise price
1.045
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
66.67K
Shares owned
N/A
Exercise price
0.72
Expiration
—
Exercise window
—
Total
Underlying
238.33K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 0.23 | — | — | 150K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 1.045 | — | — | 21.67K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 0.72 | — | — | 66.67K | N/A |
| Total | 238.33K | 0.00 | ||||